Astera Labs (NASDAQ:ALAB) Trading Up 12.4% – What’s Next?

Posted by Stanley Muller on Sep 23rd, 2026

Shares of Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) were up 12.4% during mid-day trading on Monday . The company traded as high as $343.00 and last traded at $340.74. Approximately 6,070,613 shares changed hands during mid-day trading, an increase of 15% from the average daily volume of 5,258,738 shares. The stock had previously closed at $303.25.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on ALAB shares. Citigroup reiterated a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Needham & Company LLC increased their price target on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Stifel Nicolaus lifted their price objective on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. UBS Group reiterated a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. Finally, Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 target price for the company in a report on Monday, August 17th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $348.33.

View Our Latest Stock Analysis on ALAB

Astera Labs Stock Performance

The firm has a market cap of $62.50 billion, a price-to-earnings ratio of 177.90 and a beta of 3.77. The business’s 50-day moving average is $302.93 and its 200-day moving average is $269.80.

Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same period in the previous year, the business earned $0.44 earnings per share. The company’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In related news, General Counsel Philip Mazzara sold 6,801 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the sale, the general counsel directly owned 96,542 shares of the company’s stock, valued at $32,872,551. This trade represents a 6.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 3,505 shares of Astera Labs stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total value of $963,734.80. Following the completion of the transaction, the director owned 50,456 shares of the company’s stock, valued at approximately $13,873,381.76. The trade was a 6.50% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 591,558 shares of company stock worth $209,458,976 over the last 90 days. Company insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in shares of Astera Labs during the second quarter worth $6,609,581,000. Bank of America Corp DE bought a new position in Astera Labs in the second quarter valued at about $1,061,791,000. Atreides Management LP boosted its holdings in Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after acquiring an additional 1,754,593 shares during the last quarter. Artisan Partners Limited Partnership acquired a new stake in Astera Labs in the fourth quarter worth about $148,980,000. Finally, Goldman Sachs Group Inc. increased its position in Astera Labs by 189.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after purchasing an additional 858,693 shares during the period. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.